KRAS and colorectal carcinoma: In this study, the OS of patients was examined based on the status of KRAS and PTEN. In agreement with other studies (9, 10, 19), survival analysis in CRC patients indicated that loss of PTEN gene expression or reduced expression of PTEN could cause reduced survival.